Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Comparative study of various subpopulations of cytotoxic cells in blood and ascites from patients with ovarian carcinoma

S. Lukesova, V. Vroblova, J. Tosner, J. Kopecky, I. Sedlakova, E. Čermáková, D. Vokurkova, O. Kopecky,

. 2015 ; 19 (4) : 290-9. [pub] 20150918

Jazyk angličtina Země Polsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc16000892

AIM OF THE STUDY: A number of observations have indicated that the immune system plays a significant role in patients with epithelial ovarian cancer (EOC). In cases of EOC, the prognostic significance of tumour infiltrating lymphocytes has not been clearly explained yet. The aim is to determine the phenotype and activation molecules of cytotoxic T cell and NK cell subpopulations and to compare their representation in malignant ascites and peripheral blood in patients with ovarian cancer. MATERIAL AND METHODS: Cytotoxic cells taken from blood samples of the cubital vein and malignant ascites were obtained from 53 patients with EOC. Their surface and activation characteristics were determined by means of a flow cytometer. Immunophenotype multiparametric analysis of peripheral blood lymphocytes (PBLs) and tumour infiltrating lymphocytes (TILs) was carried out. RESULTS: CD3(+) T lymphocytes were the main population of TILs (75.9%) and PBLs (70.9%). The number of activating T cells was significantly higher in TILs: CD3(+)/69(+) 6.7% vs. 0.8% (p < 0.001). The representation of (CD3(-)/16(+)56(+)) NK cells in TILs was significantly higher: 11.0% vs. 5.6% (p = 0.041); likewise CD56(bright) and CD-56(bright) from CD56(+) cells were higher in TILs (both p < 0.001). The activation receptor NKG2D was present in 45.1% of TILs vs. 32.3% of PBLs (p = 0.034), but we did not find a significant difference in the numbers of CD56(+)/NKG2D(+) in TILs and PBLs. CONCLUSIONS: These results prove that the characteristics and intensity of anti-tumour responses are different in compared compartments (ascites/PBLs). The knowledge of phenotype and functions of effector cells is the basic precondition for understanding the anti-tumour immune response.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16000892
003      
CZ-PrNML
005      
20210121105135.0
007      
ta
008      
160108s2015 pl f 000 0|eng||
009      
AR
024    7_
$a 10.5114/wo.2015.54388 $2 doi
035    __
$a (PubMed)26557777
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a pl
100    1_
$a Lukesova, Sarka $u Department of Oncology, District Hospital Nachod, Department of Clinical Microbiology, Faculty of Medicine, Charles University in Prague, Hradec Kralove, Czech Republic.
245    10
$a Comparative study of various subpopulations of cytotoxic cells in blood and ascites from patients with ovarian carcinoma / $c S. Lukesova, V. Vroblova, J. Tosner, J. Kopecky, I. Sedlakova, E. Čermáková, D. Vokurkova, O. Kopecky,
520    9_
$a AIM OF THE STUDY: A number of observations have indicated that the immune system plays a significant role in patients with epithelial ovarian cancer (EOC). In cases of EOC, the prognostic significance of tumour infiltrating lymphocytes has not been clearly explained yet. The aim is to determine the phenotype and activation molecules of cytotoxic T cell and NK cell subpopulations and to compare their representation in malignant ascites and peripheral blood in patients with ovarian cancer. MATERIAL AND METHODS: Cytotoxic cells taken from blood samples of the cubital vein and malignant ascites were obtained from 53 patients with EOC. Their surface and activation characteristics were determined by means of a flow cytometer. Immunophenotype multiparametric analysis of peripheral blood lymphocytes (PBLs) and tumour infiltrating lymphocytes (TILs) was carried out. RESULTS: CD3(+) T lymphocytes were the main population of TILs (75.9%) and PBLs (70.9%). The number of activating T cells was significantly higher in TILs: CD3(+)/69(+) 6.7% vs. 0.8% (p < 0.001). The representation of (CD3(-)/16(+)56(+)) NK cells in TILs was significantly higher: 11.0% vs. 5.6% (p = 0.041); likewise CD56(bright) and CD-56(bright) from CD56(+) cells were higher in TILs (both p < 0.001). The activation receptor NKG2D was present in 45.1% of TILs vs. 32.3% of PBLs (p = 0.034), but we did not find a significant difference in the numbers of CD56(+)/NKG2D(+) in TILs and PBLs. CONCLUSIONS: These results prove that the characteristics and intensity of anti-tumour responses are different in compared compartments (ascites/PBLs). The knowledge of phenotype and functions of effector cells is the basic precondition for understanding the anti-tumour immune response.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Vroblova, Vladimira $u Department of Clinical Immunology and Allergology, University Hospital in Hradec Kralove, Czech Republic.
700    1_
$a Tosner, Jindrich $u Department of Obsterics, University Hospital in Hradec Kralove; Faculty of Medicine, Charles University in Prague, Hradec Kralove, Czech Republic.
700    1_
$a Kopecky, Jindrich $u Department of Oncology and Radiotherapy, University Hospital in Hradec Kralove; Faculty of Medicine, Charles University in Prague, Hradec Kralove, Czech Republic.
700    1_
$a Sedlakova, Iva $u Department of Obsterics, University Hospital in Hradec Kralove; Faculty of Medicine, Charles University in Prague, Hradec Kralove, Czech Republic.
700    1_
$a Čermáková, Eva $u Department of Medical Biophysics, Computer Technology Center; Faculty of Medicine, Charles University in Prague, Hradec Kralove, Czech Republic.
700    1_
$a Vokurkova, Doris $u Department of Obsterics, University Hospital in Hradec Kralove; Faculty of Medicine, Charles University in Prague, Hradec Kralove, Czech Republic.
700    1_
$a Kopecky, Otakar $u Department of Oncology, District Hospital Nachod, Department of Clinical Microbiology, Faculty of Medicine, Charles University in Prague, Hradec Kralove, Czech Republic ; Department of Dentistry, Faculty of Medicine, Charles University in Prague, Hradec Kralove, Czech Republic.
773    0_
$w MED00165426 $t Contemporary oncology (Poznań, Poland) $x 1428-2526 $g Roč. 19, č. 4 (2015), s. 290-9
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26557777 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160108 $b ABA008
991    __
$a 20210121105134 $b ABA008
999    __
$a ind $b bmc $g 1103173 $s 925098
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 19 $c 4 $d 290-9 $e 20150918 $i 1428-2526 $m Współczesna Onkologia $n Współcz. Onkol. $x MED00165426
LZP    __
$a Pubmed-20160108

Najít záznam

Citační ukazatele

Možnosti archivace